论文部分内容阅读
国外自80年代中期开始,大量报道用去甲氧基柔红霉素(Idarubicin,IDA)治疗急非淋、急淋白血病,有很高的缓解率。我们从1993年5月至1994年10月,应用IDA组成的IA方案、VICP方案治疗急性白血病,资料可供评价的共8例,现总结报道如下。材料与方法 8例病人均系我科住院病人,皆经临床、血象、骨髓象、细胞化学染色等检查确诊。诊断依据全国白血病会议制定和修正的急性白血病的诊断与分型标准。年龄14～43岁,中位数29.6岁。其中男性7
Since the mid-1980s, a large number of reports have reported that Idarubicin (IDA) is used to treat acute non-leaching and acute leukemia, and has a high remission rate. From May 1993 to October 1994, we used the IDA-based IA protocol and the VICP protocol to treat acute leukemia. Eight data were available for evaluation. The summary report is as follows. Materials and Methods All 8 patients were hospitalized in our department and were diagnosed by clinical, blood, bone marrow, and cytochemical staining tests. The diagnosis is based on the diagnosis and classification criteria of acute leukemia formulated and revised by the National Leukemia Conference. Age 14 to 43 years, median age 29.6 years. Male 7